Work

Figure S5 from ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

Year: 2024
Type: other
Abstract: Characterization of mutant EGFR lung cancer PDXs at single-cell resolution. Workflow for scRNA-seq on PDXs and single cell data for an additional PDX.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4396768984
Cites:
Cited by:
Related to: 10